Is there a future for probiotics in preventing Clostridium difficile-associated disease and treatment of recurrent episodes? (Q37401582)

20 August 2017

1 reference

title

Is there a future for probiotics in preventing Clostridium difficile-associated disease and treatment of recurrent episodes? (English)

1 reference

20 August 2017

0 references

Clostridium difficile

0 references

author name string

Allison Imhoff

series ordinal

1

1 reference

PubMed ID

19244145

20 August 2017

Kelly Karpa

series ordinal

2

1 reference

20 August 2017

1 February 2009

1 reference

Nutrition in Clinical Practice

20 August 2017

1 reference

20 August 2017

24

1 reference

20 August 2017

1

1 reference

20 August 2017

15-32

1 reference

Clinical management of Clostridium difficile-associated disease

20 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Implications of the changing face of Clostridium difficile disease for health care practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

C. difficile may have killed 2000 in Quebec: study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Antibiotic prescribing policy and Clostridium difficile diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Effectiveness of infection control program in controlling nosocomial Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Novel evidence suggesting Clostridium difficile is present in human gut microbiota more frequently than previously suspected

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Clinical practice. Antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Prebiotics and synbiotics in clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Probiotics in Relapsing and Chronic Diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Safety of probiotics that contain lactobacilli or bifidobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Lactobacillus sepsis associated with probiotic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Safety of probiotics: translocation and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

The use of probiotics in gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329232

21 January 2018

Identifiers

DOI

10.1177/0884533608329232

1 reference

20 August 2017

1 reference

PubMed ID

19244145